S-ICD™ System

Subcutaneous Implantable Defibrillator

Protection Without Touching the Heart

The S-ICD System is the world's first and only subcutaneous implantable defibrillator that provides protection from sudden cardiac arrest (SCA) while leaving the heart and vasculature untouched.

Key Resources

Indications, Safety, and Warnings Patient Information Reimbursement Resources


Product Details

SQ-RX Pulse Generator Mechanical Specifications
Model Number 1010
Size (W x H x D) 78.2 x 65.5 x 15.7 mm
Mass 145 g
Volume 69.9 cc
Projected Longevity Normal use*: 5 years
Electrode Compatibility Requires Q-TRAK subcutaneous electrode

* Defined as 3 full-energy capacitor charges per year.

Full product details

Ordering Information

Model Number Description
1010 Pulse Generator
3400/3010* Electrode
4760 Suture Sleeve
4710/4010* Electrode Insertion Tool
3200 Tablet Programmer

* 3010 and 4010 are Cameron Health Model Numbers.  

Clinical Information

The 2-year Results from a Pooled Analysis of the IDE Study and EFFORTLESS Registry further supports the safety and efficacy of the S-ICD System. The US IDE Study, EFFORTLESS Registry and Pooled Analysis have been instrumental in demonstrating the S-ICD System as a compelling solution for the treatment of sudden cardiac arrest in a broad range of patients.

Learn more about the results of the data


Award-Winning Technology

In 2013, Boston Scientific proudly announced that the S-ICD System received the prestigious Prix Galien USA Award for "Best Medical Technology". The Galien Foundation fosters and recognizes excellence in scientific innovation to improve the state of human health. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

"We are thrilled to be recognized by the Galien Foundation and honored to be among such a prestigious group of recipients of this year's award. We strive to introduce innovative medical technologies that can help improve patient outcomes. The S-ICD System represents a truly innovative medical product and one that has been shown to be a great alternative to traditional ICDs for the treatment of life-threatening ventricular arrhythmias."

Joe Fitzgerald
President, Cardiac Rhythm Management
Boston Scientific

For more information, visit www.galienfoundation.org

Image of the Prix Galien USA Award for